van Anken, I
doi: 10.2147/DDDT.S556231, Summary Keywords fibrosis, glucagon-like peptide-1 receptor agonists, inflammation, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease Citation Lu X and Yang L (2026) Glucagon-like peptide-1 and dual/triple receptor agonists in the treatment of metabolic dysfunction-associated steatotic liver disease: advances in mechanistic research

Cycle structures for different goals General anti-aging and skin health: 4 weeks on, 4 weeks off Repeat cycles as needed Many users report retained benefits during off periods for skin-related effects Injury recovery: 6-8 weeks continuous, or until recovery milestone achieved May use intensive protocol initially, tapering to standard after 2 weeks Minimum 4-week break before starting new cycle Athletic recovery and performance: 4 weeks on, 2 weeks off Can continue rotating cycles during training blocks Take extended 4-6 week break every 3-4 cycles Chronic condition support: Longer cycles of 8-12 weeks may be appropriate under medical supervision Lower maintenance dosing during extended use Regular assessment of continued benefit versus potential tolerance What happens during rest periods Many of the structural benefits, collagen remodeling , tissue repair, improved skin texture, persist beyond active peptide use

Epitalon is widely discussed within longevity and regenerative medicine because of its relationship with telomerase activity and cellular renewal processes
Patients start at 2.5 mg weekly and increase in 2.5 mg increments every four weeks, eventually reaching maintenance doses of 10 mg or 15 mg depending on tolerance and response